These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1069 related articles for article (PubMed ID: 10620449)
1. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449 [TBL] [Abstract][Full Text] [Related]
2. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix. Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa]. Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669 [TBL] [Abstract][Full Text] [Related]
5. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976 [TBL] [Abstract][Full Text] [Related]
6. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121 [TBL] [Abstract][Full Text] [Related]
7. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246 [TBL] [Abstract][Full Text] [Related]
8. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone. Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Lee CC; Tang SG; Hsueh S Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):492-9. PubMed ID: 15925454 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix. Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix. Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503 [TBL] [Abstract][Full Text] [Related]
12. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix]. Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418 [TBL] [Abstract][Full Text] [Related]
13. [Risk factors and prognosis of node-positive cervical carcinoma]. Feng SY; Zhang YN; Liu JG Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145 [TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279 [TBL] [Abstract][Full Text] [Related]
15. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer. van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery]. Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341 [TBL] [Abstract][Full Text] [Related]
17. CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group. Kulpa J; Wójcik E; Radkowski A; Kolodziejski L; Stasik Z Anticancer Res; 2000; 20(6D):5035-40. PubMed ID: 11326663 [TBL] [Abstract][Full Text] [Related]
18. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis. Yuan CC; Wang PH; Ng HT; Tsai LC; Juang CM; Chiu LM Eur J Gynaecol Oncol; 2002; 23(1):17-20. PubMed ID: 11876385 [TBL] [Abstract][Full Text] [Related]
19. Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix. Ikeda S; Yoshimura K; Onda T; Kasamatsu T; Kato T; Ishikawa M; Sasajima Y; Tsuda H J Obstet Gynaecol Res; 2012 Oct; 38(10):1260-5. PubMed ID: 22563932 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]